Aztreonam-avibactam activity against Enterobacterales from United States medical centers: Summary of 5 years of surveillance prior to approval for clinical use (2020-2024)

Emblaveo (aztreonam/avibactam) - Pfizer, AbbVie

https://idweek2026.eventscribe.net/fsPopup.asp?PosterID=837726&mode=posterInfo

Helio Sader; Rodrigo E. Mendes, PhD (he/him/his); Dmitri Debabov, PhD. Molecular biology; Hank Kimbrough, PhD; Krisztina M. Papp-Wallace, PhD (she/her/hers)

Sep 6, 2026